A Dose-finding Trial of OPC-34712 in Patients With Schizophrenia

NCT01451164 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

459

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: OPC-34712
DRUG: OPC-34712
DRUG: OPC-34712
DRUG: Placebo

Sponsor

Otsuka Pharmaceutical Co., Ltd.